Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
5,212,242
-
Share change
-
-1,321,344
-
Total reported value
-
$3,760,238
-
Price per share
-
$0.72
-
Number of holders
-
22
-
Value change
-
-$1,271,737
-
Number of buys
-
4
-
Number of sells
-
16
Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q1 2022
As of 31 Mar 2022,
VTV THERAPEUTICS INC - CL A (VTVT) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,212,242 shares.
The largest 10 holders included
VANGUARD GROUP INC, Samsara BioCapital, LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, CIM INVESTMENT MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BOOTHBAY FUND MANAGEMENT, LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.